UnknownNot applicableNCT04712214
Use of Non-invasive Optical Analysis in Neurosurgery
Studying Benign schwannoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imperial College London
- Principal Investigator
- Kevin O'Neill, MD, FRCSImperial College of London, Charing Cross Hospital
- Intervention
- Intra-operative multispectral / hyperspectral analysis(device)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- Imperial College NHS Trust, Charing Cross Hospital, London, England, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04712214 on ClinicalTrials.govOther trials for Benign schwannoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07078136Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor DiagnosisHuazhong University of Science and Technology
- RECRUITINGNANCT05139277Evaluation of the CONVIVO SystemDartmouth-Hitchcock Medical Center
- RECRUITINGNCT05576103Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsJona Hattangadi-Gluth
- RECRUITINGNCT06421805Establishing Prospective Mediastinal Tumor Database of PUMCHPeking Union Medical College Hospital
- RECRUITINGNCT05254197SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)Seoul National University Hospital